Phreesia Net Profit Margin 2019-2024 | PHR
Phreesia net profit margin from 2019 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Phreesia Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-07-31 | $0.39B | $-0.10B | -25.90% |
| 2024-04-30 | $0.37B | $-0.12B | -32.09% |
| 2024-01-31 | $0.36B | $-0.14B | -38.66% |
| 2023-10-31 | $0.34B | $-0.15B | -42.77% |
| 2023-07-31 | $0.32B | $-0.15B | -47.81% |
| 2023-04-30 | $0.30B | $-0.16B | -53.97% |
| 2023-01-31 | $0.28B | $-0.18B | -62.63% |
| 2022-10-31 | $0.26B | $-0.18B | -70.23% |
| 2022-07-31 | $0.25B | $-0.18B | -73.47% |
| 2022-04-30 | $0.23B | $-0.16B | -68.86% |
| 2022-01-31 | $0.21B | $-0.12B | -54.93% |
| 2021-10-31 | $0.20B | $-0.08B | -40.10% |
| 2021-07-31 | $0.18B | $-0.05B | -27.93% |
| 2021-04-30 | $0.16B | $-0.03B | -19.63% |
| 2021-01-31 | $0.15B | $-0.03B | -18.24% |
| 2020-10-31 | $0.14B | $-0.02B | -16.55% |
| 2020-07-31 | $0.13B | $-0.02B | -13.43% |
| 2020-04-30 | $0.13B | $-0.08B | -63.85% |
| 2020-01-31 | $0.13B | $-0.09B | -73.60% |
| 2019-07-31 | $0.08B | $-0.10B | -117.86% |
| 2019-04-30 | $0.08B | $-0.04B | -51.28% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.252B | $0.356B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.978B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.055B | 188.82 |
| Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
| Axonics (AXNX) | United States | $3.602B | 1762.00 |
| IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
| Privia Health (PRVA) | United States | $2.736B | 228.00 |
| Enovis (ENOV) | United States | $2.646B | 17.94 |
| Omnicell (OMCL) | United States | $2.263B | 74.03 |
| Azenta (AZTA) | United States | $2.242B | 127.33 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
| Schrodinger (SDGR) | United States | $1.422B | 0.00 |
| Standard BioTools (LAB) | United States | $0.830B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Talkspace (TALK) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
| Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| TruBridge (TBRG) | United States | $0.214B | 62.22 |
| P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.050B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| CareCloud (CCLD) | United States | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |